Roswell Park Cancer Institute
Roswell Park Cancer Institute, founded in 1898, is the nation’s first cancer research, treatment and education center and is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. RPCI is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers. Roswell Park has affiliate sites and collaborative programs in New York, Pennsylvania and in China. CBLI has an exclusive, open-ended license agreement with Roswell Park.

The Cleveland Clinic
Cleveland Clinic is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties.

ChemBridge Corporation
ChemBridge Corporation is an established leader in combinatorial chemistry and in manufacturing diverse chemical libraries, which is demonstrated by its multiple collaborative agreements with the leading Pharma companies. Dr. Gudkov's group has a strong, long-term working relationship with ChemBridge. This relationship has already resulted in the isolation of bioactive small molecules with clinical potential that helped to establish either new therapeutic concepts (p53 inhibitors). CBLI has entered into an agreement with ChemBridge, whereby ChemBridge will provide CBLI with access to a chemical library of about 200,000 compounds. This library is a key component of CBLI's drug discovery pipeline. Even more important is that ChemBridge will provide CBLI with lead optimization expertise and capabilities, which is critical for the successful drug development.

AFRRI
Armed Forces Radiobiology Research Institute (AFRRI) is a part of USUHS, which is a fully accredited federal school of medicine administered by the U.S. Department of Defense and is located in Bethesda, Maryland. AFRRI is a leader in studying the short and long-term effects of radiation injury. A principal AFRRI mission is the development of pharmaceutical agents that can be used to prevent injury from radiation caused by a nuclear accident or event. Cooperative Research and Development Agreement (CRADA) with this institution signed in September 2004 is an important component of CBLI's R&D program directed towards radiation antidotes.